Tags

Type your tag names separated by a space and hit enter

[Homocysteine as a coronary risk factor].
Vopr Pitan. 2003; 72(5):43-8.VP

Abstract

In the results numerouses clinical and epidemiological trials have shown that high level of blood homocysteine is a marker of increased risk of coronary, cerebral and peripheral atherosclerosis. Close relation between high level of homocysteine and enhanced platelet aggregation, its prooxidant action, ability to inhibit growth of endothelial cells constituted basis for proposal of homocysteine theory of atherosclerosis. In this review use soy, products its processing, folate and vitamins B6 and B12 as homocysteine reducing therapy has been also suggested in the treatment of the patients with cardiovascular diseases.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Review

Language

rus

PubMed ID

14619617

Citation

Derbeneva, S A., and A V. Pogozheva. "[Homocysteine as a Coronary Risk Factor]." Voprosy Pitaniia, vol. 72, no. 5, 2003, pp. 43-8.
Derbeneva SA, Pogozheva AV. [Homocysteine as a coronary risk factor]. Vopr Pitan. 2003;72(5):43-8.
Derbeneva, S. A., & Pogozheva, A. V. (2003). [Homocysteine as a coronary risk factor]. Voprosy Pitaniia, 72(5), 43-8.
Derbeneva SA, Pogozheva AV. [Homocysteine as a Coronary Risk Factor]. Vopr Pitan. 2003;72(5):43-8. PubMed PMID: 14619617.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Homocysteine as a coronary risk factor]. AU - Derbeneva,S A, AU - Pogozheva,A V, PY - 2003/11/19/pubmed PY - 2004/4/23/medline PY - 2003/11/19/entrez SP - 43 EP - 8 JF - Voprosy pitaniia JO - Vopr Pitan VL - 72 IS - 5 N2 - In the results numerouses clinical and epidemiological trials have shown that high level of blood homocysteine is a marker of increased risk of coronary, cerebral and peripheral atherosclerosis. Close relation between high level of homocysteine and enhanced platelet aggregation, its prooxidant action, ability to inhibit growth of endothelial cells constituted basis for proposal of homocysteine theory of atherosclerosis. In this review use soy, products its processing, folate and vitamins B6 and B12 as homocysteine reducing therapy has been also suggested in the treatment of the patients with cardiovascular diseases. SN - 0042-8833 UR - https://www.unboundmedicine.com/medline/citation/14619617/[Homocysteine_as_a_coronary_risk_factor]_ DB - PRIME DP - Unbound Medicine ER -